SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is trending as the market weighs a strong record backlog and raised long-term guidance against short-term volatility following an earnings miss and commentary regarding data center grid constraints. Investors remain divided, with many viewing the pullback as a buying opportunity given the company's central role in the multi-decade power infrastructure supercycle.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor is facing downward price pressure and community scrutiny following the exit of a prominent subnet operator, which has intensified debates regarding the network's decentralization and governance. Investors are closely monitoring the situation as they weigh the potential for long-term recovery against concerns over institutional trust and internal structural stability.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently the focus of intense community debate following the successful execution of its 13th Starship test flight, which included the deployment of next-generation Starlink satellites. While supporters highlight these technical milestones as evidence of long-term value, skeptics remain focused on the company's valuation, upcoming share lock-up expirations, and the ongoing volatility surrounding its IPO performance.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

The ARK Innovation ETF is facing intense community scrutiny as investors debate its long-term performance and the high-conviction, often contrarian, trading strategy led by Cathie Wood. Discussions frequently highlight the fund's significant underperformance compared to broader market indices like the QQQ and S&P 500, fueling polarized debates over the viability of her growth-focused investment thesis.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is surging as investors react to a planned BLA resubmission for RP1 in advanced melanoma, fueled by reports of newfound regulatory flexibility following a recent FDA leadership shakeup. The community is actively debating the durability of the company's clinical data and the sustainability of the current rally given the stock's previous regulatory setbacks and ongoing funding requirements.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as investors react to the launch of its second-generation driverless truck platform and the company's clear roadmap toward scaling operations and achieving profitability. The community is actively discussing the potential for mass adoption and significant efficiency gains, while weighing the stock's performance against broader macroeconomic headwinds.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is currently trending as shareholders and analysts dissect the company's prospects following recent regulatory developments and institutional portfolio adjustments. The community is actively debating the potential impact of pending immunotherapy reimbursement on valuation, while weighing concerns over cash runway and competitive pressures in the MRD diagnostics space.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending as investors react to a post-earnings selloff, with the community actively debating whether the decline represents a fundamental shift or a prime buying opportunity for a high-quality medical device leader. While some analysts have issued price target cuts citing competitive concerns and procedure growth slowing, many institutional followers and retail traders are focusing on the company's strong recurring revenue moat and potential for a long-term rebound.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending following the FDA approval of Auvelity for the treatment of agitation associated with Alzheimers disease, a major catalyst that significantly expands the drug's market potential. The community is actively discussing the drug's favorable safety profile and lack of a black-box warning, while anticipation builds for upcoming earnings and the potential for new international partnership deals.

Sweetgreen, Inc. owns and operates a chain of salad restaurants. It offers drinks, sides, local bowls, salads, plates, and warm bowls. The company was founded by Nicolas Jammet, Jonathan Neman, and Nathaniel E. Ru in November 2006 and is headquartered in Los Angeles, CA.

Sweetgreen Inc - Ordinary Shares - Class A

Sweetgreen is trending as market sentiment shifts positively following a significant upgrade from JP Morgan and confirmation that the chain was not implicated in a recent food safety outbreak. The community is actively debating the impact of the new wrap menu on store traffic and same-store sales, with many investors closely watching upcoming earnings as a potential catalyst for a turnaround.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is Psyence Biomedical Stock Falling Wednesday?

Psyence Biomedical faces a double-digit decline Tuesday as traders lock in gains following a massive 250% speculative rally last Thursday.read more...

PBM Stock Trips Into Spotlight Again: Rare Ibogaine Supply Edge Gets Boost From Trump’s Psychedelic Push

Equity

PBM stock extended its rally to a three-day winning streak, gaining about 182% over the period as investors focused on supply benefits in the ibogaine ecosystem.

Top Small Cap Stocks To Keep An Eye On - April 20th

Spring Valley Acquisition, Enveric Biosciences, and Psyence Biomedical are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small cap stocks are shares of...

From Concrete to Consciousness: Wall Street Chases QXO $17B Megadeal and Psychedelic Moonshots

The week’s first power hour includes a powerful cross-sector narrative: hard assets meet high-concept science. On one side, a massive consolidation in construction materials signals long-term conviction in infrastructure and development. On the other, a cluster of small- and mid-cap biotech names, many tied to next-generation mental health treatments, are catching momentum simultaneously. $PBM, $QXO, $BLD, $XERI, $TOVX, $POET, $SLNH, $ATAI, $PBM, $CMPS

ATAI Stock Soars On Track For Best Day On Trump Psychedelics Push And Wall Street Cheers

Trump on Saturday signed an executive order instructing the U.S. Food and Drug Administration to expedite the review of psychedelic drugs, spurring a rally among psychedelic drug developer stocks. 

PBM Jumps On Trump Psychedelic Push, Ibogaine Supply Story

Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-specific ibogaine supply catalyst.read more...

Rogan’s Runners Market Ignites

The market is feeling the effect of Joe Rogan getting in President Trump’s ear and psychedelic therapeutics gaining regulatory tailwinds. Meanwhile, adjacent sectors are quietly building foundational breakthroughs. Wearables are evolving into neural interfaces, biomaterials are transitioning from lab curiosity to production reality, and oncology platforms continue their grind through clinical validation. $KBLB, $WLDS, $ARTL, $ENVB, $TOVX, $PBM, $CMND, $CMPS, $HELP,

Nasdaq, S&P 500 Futures Fall, Oil Risk Back In Focus After Trump’s Iran Escalation: Why PBM, FRMI, ASTS, BATL Are Keeping Traders Engaged Today

Data from Stocktwits shows that retail positioning has remained ‘bullish’ for SPY and QQQ amid geopolitical instability. 


Why Is PBM Stock More Than Doubling Premarket Today?

Through its investment in PsyLabs, the company has built a GMP-compliant platform producing pharmaceutical-grade ibogaine.

Best Small Cap Stocks To Consider - April 17th

AltC Acquisition, Energy Focus, Critical Metals, Spring Valley Acquisition, Inflection Point Acquisition, Direxion Daily MU Bull 2X Shares, and Psyence Biomedical are the seven Small Cap stocks to...

This account has been verified as an official PBM representative.

Verified Account

Psyence BioMed

Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.

Psyence Biomedical Ltd.

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards another losing week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

PBMPsyence Biomedical Ltd.

Fundamentals

Latest PBM News